Produkty 185613-71-2

CAS 185613-71-2 występuje w naszej ofercie pod nazwami: Betamethasone EP Impurity H, Betamethasone Impurity 8（Betamethasone EP Impurity H）. Oferty producentów: Chemat Brand, Hubei YoungXin. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg.

Betamethasone EP Impurity H
Chemat Brand
  • opakowanie: on request
  • Warianty: 2
Zobacz produkt
Betamethasone Impurity 8（Betamethasone EP Impurity H）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one (CAS 185613-71-2) to związek chemiczny o wzorze sumarycznym C22H29FO5 i masie molowej 392.5 g/mol. Nazwa systematyczna IUPAC: (8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one. InChIKey: OXYIPQGDQCLIAE-RNGLRLRGSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H29FO5
Masa molowa392.5 g/mol
Nazwa IUPAC(8S,9R,10R,11S,13R,14S,16S,17R)-14-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one
InChIKeyOXYIPQGDQCLIAE-RNGLRLRGSA-N
SMILESC[C@H]1C[C@@]2([C@H]3CCC4=CC(=O)C=C[C@@]4([C@@H]3[C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)C)F

Dane obliczone przez PubChem (NCBI)

Synonimy: Betamethasone impurity H [EP], BETAMETHASONE IMPURITY H [EP IMPURITY], BETAMETHASONE IMPURITY H (EP IMPURITY), Betamethasone impurity H, Betamethasone EP Impurity H, 9-Desfluoro-14-fluoro Betamethasone
Izomery (ten sam wzór sumaryczny)
(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C22H29FO5
2-[(8S,9R,10S,11S,13S,14S,16S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyacetic acid C22H29FO5
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C22H29FO5
(8S,9R,10R,11S,13S,14R,16S,17R)-8-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C22H29FO5
(Z)-7-[(1R,2R,3R,5S)-2-[(E,3S)-3-fluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid C22H29FO5
(Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-3-fluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid C22H29FO5
(6S,8S,9S,10R,11S,13S,14S,16R,17R)-6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C22H29FO5
(2S,3S,4aS,4bS,10aS,10bR,11S,12aS)-10b-fluoro-2,11-dihydroxy-2-(hydroxymethyl)-3,10a,12a-trimethyl-3,4,4a,4b,5,6,11,12-octahydrochrysene-1,8-dione C22H29FO5
(6S,8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C22H29FO5
2-[(8S,9R,10S,11S,13S,14S,16S,17S)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyacetic acid C22H29FO5
(8S,9R,10S,11S,13S,14S,16R,17R)-4,6,6-trideuterio-17-(2,2-dideuterio-2-hydroxyacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-8,11,12,14,15,16-hexahydro-7H-cyclopenta[a]phenanthren-3-one C22H29FO5
(8S,9R,10S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C22H29FO5